Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Invested Capital: 2017-2025

Historic Return on Invested Capital for Organogenesis Holdings (ORGO) over the last 3 years, with Jun 2025 value amounting to -0.08%.

  • Organogenesis Holdings' Return on Invested Capital was N/A to -0.08% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.08%, marking a year-over-year change of. This contributed to the annual value of 0.02% for FY2023, which is 4.00% down from last year.
  • According to the latest figures from Q2 2025, Organogenesis Holdings' Return on Invested Capital is -0.08%, which was down 268.68% from -0.02% recorded in Q3 2024.
  • Organogenesis Holdings' Return on Invested Capital's 5-year high stood at 0.33% during Q2 2021, with a 5-year trough of -0.08% in Q2 2025.
  • Its 3-year average for Return on Invested Capital is 0.01%, with a median of 0.02% in 2024.
  • Data for Organogenesis Holdings' Return on Invested Capital shows a maximum YoY dropped of 7bps (in 2024) over the last 5 years.
  • Over the past 5 years, Organogenesis Holdings' Return on Invested Capital (Quarterly) stood at 0.28% in 2021, then reached 0.06% in 2022, then dropped by 4bps to 0.02% in 2023, then declined by 7bps to -0.02% in 2024, then reached -0.08% in 2025.
  • Its Return on Invested Capital was -0.08% in Q2 2025, compared to -0.02% in Q3 2024 and 0.02% in Q1 2024.